SEQUENT — Sequent Scientific Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹37.51bn
- IN₹42.33bn
- IN₹13.70bn
- 90
- 10
- 60
- 56
Annual cashflow statement for Sequent Scientific, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | — | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 941 | 1,455 | 534 | -1,377 | -546 |
| Depreciation | |||||
| Non-Cash Items | 408 | 334 | 422 | 1,650 | 834 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -702 | -1,147 | -1,146 | -663 | -597 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 1,153 | 1,148 | 321 | 168 | 306 |
| Capital Expenditures | -407 | -528 | -325 | -862 | -356 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -315 | 625 | -631 | 212 | 297 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -723 | 96.5 | -956 | -650 | -59.2 |
| Financing Cash Flow Items | -360 | -227 | -179 | -359 | -454 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -428 | -1,388 | 673 | 322 | -14.4 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.07 | -144 | 37.5 | -159 | 232 |